Clinical Trials

Fostamatinib – Warm Autoimmune Hemolytic Anemia

A Phase 3, multi-center, randomized, double-blind, placebo-controlled study of fostamatinib disodium in the treatment of warm Autoimmune Hemolytic Anemia (wAIHA). The purpose of this study is to assess the safety and efficacy of fostamatinib in subjects with wAIHA.